Data is not available at this time.
Lifeway Foods, Inc. operates in the dairy and probiotic food products industry, specializing in kefir and other cultured dairy products. The company generates revenue primarily through the production and distribution of its branded and private-label products, sold via retail, foodservice, and e-commerce channels. Lifeway has carved a niche in the health-conscious consumer segment, leveraging the growing demand for functional foods that support gut health and immunity. Its market position is bolstered by a vertically integrated supply chain, proprietary fermentation processes, and a strong distribution network across North America. The company competes with both large dairy conglomerates and smaller organic brands, differentiating itself through product innovation and a focus on organic, non-GMO, and probiotic-rich offerings. Lifeway’s strategic partnerships with major retailers and expansion into plant-based alternatives further strengthen its competitive edge in the evolving health food sector.
Lifeway Foods reported revenue of $186.8 million for the fiscal year ending December 31, 2024, with net income of $9.0 million, translating to a diluted EPS of $0.59. Operating cash flow stood at $13.0 million, reflecting efficient working capital management. Capital expenditures of $6.7 million indicate ongoing investments in production capacity and innovation, supporting long-term growth.
The company demonstrates solid earnings power, with a net margin of approximately 4.8%. Its capital efficiency is evident in its ability to generate positive operating cash flow while maintaining modest debt levels. The absence of significant leverage allows Lifeway to reinvest in growth initiatives without undue financial strain.
Lifeway’s balance sheet remains robust, with $16.7 million in cash and equivalents and minimal total debt of $117,000. This strong liquidity position provides flexibility for strategic investments or potential acquisitions. The company’s low debt-to-equity ratio underscores its financial stability and low-risk profile.
Lifeway has shown consistent revenue growth, driven by increasing consumer demand for probiotic-rich foods. The company does not currently pay dividends, opting instead to reinvest profits into expansion and product development. This aligns with its growth-focused strategy and the dynamic nature of the health food market.
With a market capitalization derived from its share price and 14.8 million shares outstanding, Lifeway’s valuation reflects investor confidence in its niche market positioning and growth potential. The absence of dividends suggests the market anticipates future earnings growth and capital appreciation.
Lifeway’s strategic advantages include its strong brand recognition, proprietary fermentation technology, and diversified distribution channels. The outlook remains positive, supported by trends favoring functional foods and the company’s ability to innovate. Challenges include competitive pressures and input cost volatility, but Lifeway’s focus on premium, health-focused products positions it well for sustained growth.
Company filings (10-K), investor presentations
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |